Plain-English translation of NCT03836950 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing repetitive transcranial magnetic stimulation (rTMS)—a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain—to see if it can help improve thinking and memory problems in veterans with Parkinson's disease. Researchers want to understand whether this treatment is safe and whether it can actually help people think more clearly and manage daily tasks better. The study will also use brain imaging to see how the treatment affects the brain's connections.
People with Parkinson's disease often develop problems with thinking, memory, and planning—called mild cognitive impairment—which can make daily life harder. Right now, there are limited treatment options for these cognitive problems, so researchers are exploring whether this magnetic brain stimulation approach could offer a new way to help.
You likely qualify if…
You likely don't qualify if…
If you're selected for this study, you'll be randomly assigned to receive either active magnetic stimulation or a sham (placebo) treatment—neither you nor the researchers will know which one you're getting. You'll come in for rTMS sessions, and before, after, and one month later, you'll complete thinking and memory tests. Some participants will also have brain imaging scans to help researchers understand how the treatment affects the brain.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States